ArticleFrontiers in aging neuroscience2025
Risk prediction of recurrent ischemic stroke based on Carotid Plaque-RADS: construction and validation of a nomogram model.
Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Contrast-enhanced ultrasound for reclassification of moderate-risk carotid plaques (Plaque-RADS 3).BMC medical imaging · 2026Article
- Distribution of high-resolution magnetic resonance imaging -based carotid Plaque-RADS subtypes among patients with acute cerebral infarction.Neuroradiology · 2026Article
- Article
- Assessing the Prognostic Significance of Ultrasound - Detected Carotid Plaque Morphology in Predicting Ischemic Stroke Risk Among Postmenopausal Women.International journal of women's health · 2026Article
- CT angiography-derived plaque and perivascular fat radiomics for predicting ipsilateral stroke recurrence in patients with carotid atherosclerosis.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and purpose: Ischemic stroke (IS) is characterized by a high recurrence rate and more serious repercussions. Recently, the Carotid Plaque Reporting and Data System (Carotid Plaque-RADS) has been introduced to gauge and forecast the risk of cerebrovascular incidents. More studies are required to confirm its predictive power for recurrent ischemic stroke (RIS). We aimed to create a nomogram model that can evaluate the likelihood of RIS, with Carotid Plaque-RADS serving as a crucial instrument in this model. Methods: We carried out a retrospective review of 286 patients diagnosed with acute IS at the Second Affiliated Hospital of Guangzhou University of Chinese Medicine between January 2020 and January 2025. The study population consisted of two groups: the IS group (129 patients) and the RIS group (157 patients), depending on whether they experienced a recurrence of IS. Carotid ultrasound examination and clinical data were gathered and classified according to Carotid Plaque-RADS. Independent risk factors for the RIS were determined using multivariate logistic regression analyses. Subsequently, we developed a nomogram model to forecast RIS risk and evaluated its performance. Results: The RIS and IS groups showed significant differences in low-density lipoprotein (LDL), hypertension, atrial fibrillation, severe carotid stenosis, and Carotid Plaque-RADS categories. Multivariate logistic regression analysis identified LDL, hypertension, atrial fibrillation, severe carotid stenosis, and Carotid Plaque-RADS as independent risk factors for RIS. The nomogram model built using these risk factors demonstrated good calibration (H-L goodness-of-fit test Conclusion: The nomogram model based on Carotid Plaque-RADS provides a novel and effective tool for clinical risk assessment and demonstrates favorable predictive performance for RIS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.